Colliers Life Science Team | @Colliers_Boston #Cambridge | Experienced #CRE advisors working with #LifeScience #Biomanufacturing & emerging #Biotech companies
Cambridge, MA
Joined June 2017
- Tweets286
- Following635
- Followers158
- Likes304
8 Tips for Converting Office Space to #LifeSciences Labs
bdcnetwork.com/8-tips-conver…
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
#CRE #Biomanufacturing #lifesciences #BigPharma #cGMP #biopharma #bioprocessing #Boston
biopharminternational.com/vi…
Honored to be a part of this important deal for MA/Biotech.
assemblymag.com/articles/960…
Well written and informative as always my friend. Thx for sharing
Record-Breaking Biotech Funding Tsunami Of 1H2020
Largest amount of quarterly VC funding ever.
Largest amount raised in biotech IPOs in a quarter.
Largest total equity capital raised in a quarter.
Hopefully we will make new drugs with it!
lifescivc.com/2020/07/the-re…
2
Colliers Life Science | Boston retweeted
Congrats to @Merck and @dewpoint_tx for starting a new partnership and approach to an important unmet need!
Thrilled to be teaming up with @Merck and putting our platform to work translating the science of biomolecular condensates and phase transition into a brand-new kind of HIV treatment.
dewpointx.com/news/dewpoint-…
Colliers Life Science | Boston retweeted
I still believe in this great country. Flawed, but great. Driven by amazing citizens, individualism, freedom of speech, unsurpassed creativity, and the capacity to change. We are strong and we will change, and we will emerge better, as we have before in the face of adversity.
Colliers Life Science | Boston retweeted
5 FDA-approved antivirals could target COVID-19: study dlvr.it/RZq1Q6
Colliers Life Science | Boston retweeted
2 months after launch, QurAlis nabs early ALS compounds from Eli Lilly dlvr.it/RZl6zv
Congrats to our #biotech client, @EveloBio , on its successful Nasdaq debut. #KendallSquare #Cambridge teapaw.org/endpts/status/99415408…
Evelo Bio grabs $85M as the latest early-stage biotech debuts on Nasdaq endpts.com/evelo-bio-grabs-8…
1
Take a look at Alexandria's latest apartment complex in #KendallSquare #Cambridge via @BosBizJournal bit.ly/2H8d6pq
2
Alexandria will launch its own #biotech incubator in #KendallSquare #Cambridge via @BosBizJournal bit.ly/2JHPauK
Further coverage on our client @908Devices and their 37,500 SF lease at 645 Summer Street #Seaport #Boston bit.ly/2GIPASP
Great press on our client @908Devices - the #Seaport based company will double in size for its new HQ and ramp up production of its devices via @BosBizJournal bit.ly/2GTZjU0
John Hancock to move headquarters from Seaport to Back Bay bizjournals.com/boston/news/… via @BosBizJournal
Colliers Life Science | Boston retweeted
Surface Oncology Inc. files for $75M IPO lnkd.in/ezcmhGa lnkd.in/eQGgpVe
Colliers Life Science | Boston retweeted
Q1 Cambridge #CRE activity displayed in Maptrends as @CXCambridge Philips lease shifts commercial balance. Slate-Cambridge out today! ecs.re/slatecam181 @EastCambBiz @ABetterCambMA @Cambridge_Side @CambridgeChambr
#Cambridge backed TCR2 raises $125M in Series B #funding #biotech #lifescience teapaw.org/JohnCendpts/status/976…
Another mega-startup: China investors back TCR2’s $125M cash round to fuel a preclinical assault on solid tumors
endpts.com/another-mega-star…
1
Excited for our client @DesktopMetal on closing their $65M round of #funding - #3Dprinting #Burlington bit.ly/2pqZSwT teapaw.org/jrexbos/status/9758383…
1